Metraipolis › archive › dc_6ea0ee556e71

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD) — Europe PMC PMID:41053100

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41053100
DOI
10.1038/s41419-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-09T13:46:35.153Z
SHA-256 of the archived text
5870b9e95e4a2a86dfeb9c19c5be2876daff3e9e7a737f1a18128c9a8e8982ec
Stable URL of this page
https://metraipolis.com/documento/dc_6ea0ee556e71

How to cite

Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD) — Europe PMC PMID:41053100 — Europe PMC (en), https://europepmc.org/article/MED/41053100 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ea0ee556e71 (Metraipolis archive dc_6ea0ee556e71, sha256 5870b9e95e4a2a86dfeb9c19c5be2876daff3e9e7a737f1a18128c9a8e8982ec)
BibTeX
@misc{dc6ea0ee556e71,
  title = {Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD) — Europe PMC PMID:41053100},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41053100},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ea0ee556e71; sha256 5870b9e95e4a2a86dfeb9c19c5be2876daff3e9e7a737f1a18128c9a8e8982ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053100. Agents can read the archived copy with the MCP tool read_document.